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Research
Studies in laboratory animals have unequivo­
cally demonstrated that exposures to exogenous 
estrogens during certain periods of embryonic, 
fetal, and neo  natal development lead to perma­
nent and detrimental changes in reproductive 
function, most notably structural malforma­
tions among the reproductive tissues, reduced 
fertility, and cancer (Marselos and Tomatis 
1992, 1993). Diethylstilbestrol (DES), a highly 
potent, orally available synthetic estrogen, 
is perhaps the most studied among the class 
of exogenous estrogens since being strongly 
associated with vaginal adeno  carcinoma and 
abnormalities of the uterus and cervix in young 
women who were exposed via pharmacologi  cal 
use by their mothers during pregnancy (Herbst 
et al. 1971). Although DES was proscribed 
for use in women during pregnancy in 1973, 
these findings are the origin of the still cur­
rently held hypothesis that unintended expo­
sures to compounds with estrogenic activities, 
such as phyto  estrogens (e.g., genistein and 
coumestrol), pesticides [e.g., DDT (dichloro­
diphenyl  trichloroethane) and DDE (dichloro­
diphenyl  dichloroethylene)], and plasticizers 
(e.g., bisphenol A), during embryonic through 
post  natal development may be linked to   
certain reproductive and other abnormalities 
in humans. 
Many of the pathologies associated with 
develop  mental exposure to DES in humans 
can be replicated in outbred and inbred strains 
of laboratory mice (McLachlan et al. 1980; 
Newbold 2004). A few studies have focused 
on the health problems of men exposed to 
DES in utero (known as DES sons), and the 
results have been mixed. The most consistent 
finding indicates an increased risk for non­
cancerous epididymal cysts (Bibbo et al. 1977; 
Conley et al. 1983; Gill et al. 1979; Niculescu 
1985; Wilcox et al. 1995); an increased risk 
of testicular cancer has not been ruled out 
but is not yet confirmed. The rele  vancy of the 
present protocol to DES sons is supported by 
previous studies in mice showing that expo­
sure periods considered susceptible to per­
turbation by DES include exposure during 
gestation days (GDs) 9–16, on GD18 alone, 
and on post  natal days (PNDs) 1–5 (Newbold 
et al. 2000). Outbred female mice treated with 
DES as neo  nates develop a high incidence 
of uterine adeno  carcinoma (Newbold et al. 
1990); similarly treated male mice develop 
testicular cancer and abnormalities of the pros­
tate and seminal vesicles (SVs) (McLachlan 
1977). Since reports of these findings were 
published almost three decades ago, the fetal 
and neo  natal mouse has been used extensively 
to investigate the toxicology of estrogenic 
compounds on reproductive tract develop­
ment. Ostensibly, estrogen receptor­α (ERα) 
gene (Esr1)­knockout (αERKO) and ERβ 
(Esr2)­knockout (βERKO) mice have added 
to our ability to investigate the mecha  nisms by 
which exogenous estrogens exert their effects 
(Couse and Korach 1999). Conclusive studies 
have demonstrated that reproductive tracts of 
female αERKO mice are largely resistant to 
the develop  mental effects of neo  natal exposure 
to DES (Couse et al. 2001). These data indi­
cate a prominent role for ERα in mediating 
the toxicological effects of DES during repro­
ductive tract development in females.
Reproductive tissues of male mice appear 
to be especially sensitive to the toxicologi­
cal effects of DES (McLachlan et al. 1975; 
Prins 1992; Prins et al. 2001), and presum­
ably other exogenous estrogens, throughout 
develop  ment. The development of the SV in 
the male reproductive tract involves three pro­
cesses (Shima et al. 1990): growth, epithelial 
branching morpho  genesis, and epithelial cyto­
differentiation. In humans, SV development 
begins from the mesonephric (or Wolffian) 
duct at approximately 12 weeks of fetal age, 
and morpho  genesis of the SV depends on 
fetal testicular androgens (Risbridger and 
Taylor 2006). At maturity, the SV consists 
of folded glandular epithelium with lumi­
nal secretory cells and a discontinuous layer 
of basal cells surrounded by a stromal layer 
of smooth muscle (Risbridger and Taylor 
2006). In the mouse, the SV is present by 
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Ba c k g r o u n d: Studies have shown that perinatal exposure to the synthetic estrogen diethylstil­
bestrol (DES) leads to feminization of the seminal vesicle (SV) in male mice, as illustrated by tissue 
hyperplasia, ectopic expression of the major estrogen­inducible uterine secretory protein lacto  ferrin 
(LF), and reduced expression of SV secretory protein IV (SVS IV).
oBjectives: The present study was designed to evaluate the role of the estrogen receptor (ER) in 
this action by using ER­knockout (ERKO) mice. 
Me t h o d s : Wild­type (WT), ERα­null (αERKO), and ERβ­null (βERKO) male mice were treated 
with either vehicle or DES (2 μg/day) on neo  natal days 1–5. These mice were divided into two 
groups: In the first group, intact mice were sacrificed at 10 weeks of age; in the second group, mice 
were castrated at 10 weeks of age, allowed to recover for 10 days, treated with dihydrotestosterone 
(DHT) or placebo, and sacrificed 2 weeks later. Body weights and SV weights were recorded, and 
mRNA expression levels of Ltf (lactoferrin), Svs4, and androgen receptor (Ar) were assessed.
re s u l t s: In DES­treated intact mice, SV weights were reduced in WT and βERKO mice but not 
in αERKO mice. DES­treated WT and βERKO males, but not αERKO males, exhibited ectopic 
expression of LF in the SV. DES treatment resulted in decreased SVS IV protein and mRNA expres­
sion in WT males, but no effect was seen in αERKO mice. In addition, DES­treated βERKO mice 
exhibited reduced Svs4 mRNA expression but maintained control levels of SVS IV protein. In DES­
treated castrated mice, DHT implants restored SV weights to normal levels in αERKO mice but 
not in WT mice, suggesting full androgen responsiveness in αERKO mice.
co n c l u s i o n s: These data suggest that DES­induced SV toxicity and feminization are primarily 
mediated by ERα; however, some aspects of androgen response may require the action of ERβ.
key w o r d s : development, endocrine disruptor, reproductive tract. Environ Health Perspect 
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embryonic day 16.5 (Lung and Cunha 1981) 
and develops from the meso  nephric ducts. 
Morphogenesis begins on GD15, and during 
the first week of postnatal life the SV under­
goes intense morpho  genesis that results in the 
complex folded structures charac  teristic of the 
mature SV (Lung and Cunha 1981). ER is 
present in the mouse SV (Yamashita 2004) 
and appears during develop  ment on PND6 
(Cooke et al. 1991). Significant increases 
in cyto  solic ER levels in the SV have been 
reported in mice following neo  natal exposure 
to DES (Turner et al. 1989).
In addition to morphological changes 
of the male reproductive tract, studies have 
shown that developmental exposure to 
estrogens leads to female­like patterns of gene 
expression in certain reproductive tissues 
during adulthood (Beckman et al. 1994; 
Newbold et al. 1989), including aberrantly 
high expression of progesterone receptor (Pgr), 
an estrogen­regulated gene, in the stromal 
cells of the male reproductive tract (Williams 
et al. 2000, 2001); ectopic expression of the 
major estrogen­inducible uterine secretory 
protein, lactoferrin (LF; also called lacto­
transferrin); and loss of constitutive expression 
of the androgen­regulated gene, SV secretory 
protein 4 (SVS IV), in the SVs (Beckman 
et al. 1994). To date, studies of DES exposure 
in ER­null male mice have focused largely on 
the prostate; these studies have demon  strated 
that ERKO males are refractory to the effects 
of neo  natal DES exposure, whereas βERKO 
males exhibit susceptibilities comparable to 
similarly treated wild­type (WT) mice (Prins 
et al. 2001). In the present study we evaluated 
the effects of neo  natal DES exposure on the 
SV of αERKO and βERKO mice.
Materials and Methods
Animals and treatment. All studies involving 
animals were conducted in accordance with 
the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals 
(Institute of Laboratory Animal Research 
2011) and approved by the National Institute 
of Environmental Health Sciences (NIEHS) 
Animal Care and Use Committee. Animals 
were treated humanely and with regard for 
alleviation of suffering. The genera  tion 
of ERα­ and ERβ­null mice is previously 
described (Krege et al. 1998; Lubahn et al. 
1993). Mice were generated by breeding   
C57/BL6 mice hetero  zygous for disruption of 
the ERα gene (Esr1) or the ERβ gene (Esr2) 
to produce homo  zygous ERα­null (αERKO) 
or ERβ­null (βERKO) mice, respectively, and 
WT litter  mates. 
Pregnant females were housed under 
controlled lighting (12­hr light/dark cycle) 
and temperature conditions and were 
provided with NIH 31 laboratory mouse 
chow (Zeigler Brothers Inc., Gardners, PA) 
and fresh water ad libitum. On the day of 
parturition, considered day l of age, male 
offspring were pooled from multiple litters 
and randomly distributed among CD­1 foster 
mothers at eight per female. All offspring 
then received a sub  cutaneous injection of 
2 μg (1–2 mg/kg/day) DES in corn oil or an 
equal volume of corn oil alone (vehicle) daily 
on PNDs 1–5. All offspring were weaned at 
21 days of age and geno  typed by polymerase 
chain reaction (PCR) on DNA extracted from 
tail biopsy using previously described methods 
(Couse et al. 2003). Mice in group 1 were 
killed at 10 weeks of age. Mice in group 2 
were castrated at 10 weeks of age and allowed 
to recover for 10 days. Mice then received a 
sub    dermal implant of a 1­cm length of sealed 
Silastic tubing (1­cm in length, 1.47 mm 
inner diameter, 1.95 mm outer diameter) 
packed with crystalline dihydro  testosterone 
(DHT) or nothing (placebo) (implants were 
kindly provided by D. Handelsman, Sydney, 
Australia), and then were killed 2 weeks later 
(Lim et al. 2008). At necropsy, we recorded 
body weights, collected and heparinized 
whole blood from the inferior vena cava, and 
stored the plasma at –70°C until assayed. We 
collected the SV, trimmed off the coagulating 
gland, and recorded the wet weight. SVs were 
snap­frozen for RNA and protein analysis 
or fixed in paraformaldehyde solution for 
histological analysis. SV tissue sections (4 μm) 
were stained with hematoxylin and eosin. 
Hormone serum assays. We evaluated serum 
estradiol and testosterone levels using Coat­
A­Count radio  immunoassay kits (Siemens 
Healthcare Diagnostics, Los Angeles, CA) 
and were assayed using an APEX automatic 
gamma counter (ICN Micromedic Systems 
Inc., Huntsville, AL).
RNA and protein isolation. Frozen SV tis­
sue from individual animals was pulverized, 
and the material was subdivided for either pro­
tein or RNA extraction. Total RNA was iso­
lated using the RNeasy isolation kit (Qiagen 
Inc., Valencia, CA) according to the manufac­
turer’s protocol. Cytoplasmic and nuclear pro­
tein was extracted from frozen pulverized SV 
tissue using the NE­PER Protein Extraction 
Kit (Pierce, Rockford, IL) according to the 
manufacturer’s protocol.
Reverse-transcriptase polymerase chain 
reaction (RT-PCR). SV RNA (0.5 μg) was 
reverse transcribed using the SuperScript First 
Strand Synthesis Kit (Invitrogen, Carlsbad, 
CA) according to manufacturer’s protocol. 
As a negative control, we used a sample con­
taining RNA but no reverse transcriptase. 
Real­time RT­PCR was performed using the 
ABI PRISM 7900HT Sequence Detection 
System (Applied Biosystems, Foster City, CA) 
and SYBR Green (Invitrogen). Primers were 
designed using Applied Biosystems Primer 
Express Software (version 2.0). 
Real­time RT­PCR was performed using 
2.5 ng cDNA. Samples were analyzed in 
duplicate, and a negative control sample was 
included on each plate. For all samples, the 
cyclophilin gene [peptidylprolyl isomerase A 
(Ppia)] was used as an endogenous control for 
normalization. Expression ratios were calcu­
lated using the mathematical model described 
by Pfaffl (2001):
2–(Ctgene of interest – CtPpia) × 10,000, 
where Ct is cycle threshold.
Western immunoblot analysis. Cytoplasmic 
SV protein (1 μg) was immobilized to nitro­
cellulose membrane using the BioRad Dot 
Blot apparatus (Bio­Rad, Hercules, CA) 
according to the manufacturer’s protocol. We 
performed the protein analysis using a single 
blot that was stripped and reprobed. Equal 
loading was determined using MEMCode total 
protein stain (Pierce) and then destained before 
Western blotting. Non  specific peroxidases 
were eliminated using 3% hydrogen peroxide, 
and non  specific sites were blocked with 10% 
bovine serum albumin in Tris­buffered saline, 
pH 7.4, plus 0.1% Tween­20 (TBS­T). Blots 
were then incubated with primary anti  bodies 
for 1 hr at room temperature. Anti­mouse SV 
secretory protein IV (SVS IV) rabbit polyclonal 
antibody, a gift from T. Teng (NIEHS), and 
rabbit anti­mouse LF polyclonal antibody, 
isolated as described previously (Jefferson 
et al. 1996), were used at 1:5,000 dilution. 
Blots were then incubated with secondary 
antibody, anti­rabbit horseradish peroxidase 
(Amersham, Piscataway, NJ), diluted 1:10,000 
in TBS­T. Membranes were washed five times 
for 5 min each in TBS­T, and immuno­
reactive bands were visualized using WestDura 
Reagent (Pierce) following the manufacturer’s 
instructions. Blots were exposed to film for 
1 min, and images were captured by a camera 
(model c8484­54­03G) using LabWorks s46 
software (both from UVP BioImaging Systems, 
Upland, CA).
Statistical analysis. The data were analyzed 
using JMP software (version 7) and SAS soft­
ware (version 9.1), both from SAS Institute 
Inc. (Cary, NC). For body weight and SV wet 
weight, parametric tests were used to compare 
values. We evaluated real­time RT­PCR data 
using analysis of variance (ANOVA) followed 
by Tukey’s test. For estrogen and testosterone 
levels, statistical significance was determined 
using t­test, and groups were compared using 
non  parametric Mann­Whitney tests. p­Values 
< 0.05 were considered statistically significant. 
Results
DES Exposed αERKO male mice retain 
androgen responsiveness in SV. The SVs of 
adult WT males exposed to DES as neo  nates 
exhibited a 50% reduction in weight relative 
to untreated WT controls (Figure 1). This Walker et al.
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is consistent with previous reports (Prins 
et al. 2001) and indicates that DES treat­
ments were successful. DES­exposed βERKO 
males exhibited a remarkably similar effect 
(Figure 1). In contrast, DES exposure had no 
measurable effect on SV weights in αERKO 
males. Instead, both DES­treated and control 
αERKO males exhibited significantly larger 
SV weights compared with age­matched WT 
and βERKO males (p < 0.05). 
Neo  natal DES exposure resulted in signifi­
cant histological alterations in the SV of WT 
and βERKO males but not αERKO males 
(Figure 2). The SV of WT mice neo  natally 
exposed to DES showed a significant increase 
in thickness of the smooth muscle layer, as 
well as the connective tissue that separates 
the epithelium from the smooth muscle layer 
(Figure 2B). The single columnar epithelial 
structure is no longer present, replaced by 
increased glandular formation. However, these 
glands do not appear to be secretory in nature 
because they did not produce the secretions 
seen in the control SV (Figure 2B). In addi­
tion, significant vasculature infiltration can 
be seen in the connective tissue layer, as well 
lymphocyte infiltration in the smooth muscle 
layer. DES­treated βERKO mice exhibited 
significant thickening and lymphocyte infil­
tration of the smooth muscle layer, similar to 
the histopathological effects observed in the 
WT mice. Despite potential hyper  plasia of the 
epithelium, apparently some of the epithelium 
remained functional because epithelial cells 
still maintained a polarized columnar shape 
and produced some secretions (Figure 2F). 
In contrast, the well­documented histologi­
cal identifiers of DES exposure in the SV 
exhibited by WT and βERKO males was not 
evident in the DES­treated αERKO males 
(Figure 2D). 
The expression of Svs4, a gene positively 
regulated by androgen in the mouse SV, was 
greatly reduced in the SVs of DES­exposed 
WT males (Figure 3A). This reduced Svs4 
expression was further confirmed by the 
absence of detectable SVS IV protein as 
evaluated by Western blot (Figure 3B). We 
observed a similar effect on Svs4 expression in 
DES­exposed βERKO males, although levels 
of SVS IV protein were more variable in this 
geno  type. Interestingly, βERKO mice retained 
SVS IV protein expression even though they 
had lower mRNA levels after DES exposure, 
unlike WT controls. These data suggest that 
some aspects of androgen response, such as 
maintenance of SVS IV protein, may require 
the action of ERβ and warrant further studies 
to evaluate a potential role for ERβ. In contrast, 
the SVs of DES­exposed αERKO males 
exhibited normal Svs4 mRNA expression and 
SVS IV protein levels compared with controls.
Because maintenance of normal weights 
and Svs4 expression in mouse SV are depen­
dent on sufficient androgen stimulation, 
abnormally low SV weights and absence of 
Svs4 expression and SVS IV protein observed 
in DES­exposed adult WT and βERKO males 
suggest that estrogen leads to a permanent 
Figure 1. SV weight (wt) measured at 10 weeks of 
age in intact male WT, αERKO, and βERKO mice 
treated neonatally with vehicle (control) or DES 
(2 μg/day on days 1–5). Treatment groups: WT con-
trol, n = 19; WT DES, n = 18; αERKO control, n = 11; 
αERKO DES, n = 20; βERKO control, n = 14; βERKO 
DES, n = 20). Data are mean ± SE. 
*p < 0.05 compared with the corresponding control, by 
parametric test. 
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Figure 2. Pathology of SVs of male WT (A,B), αERKO (C,D), and βERKO (E,F) mice treated neonatally with 
vehicle (control; A,C,E) or DES (2 μg/day on days 1–5; B,D,F). SVs are stained with hematoxylin and eosin. 
Bar = 100 µm. 
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Figure 3. SVS IV expression in SVs of adult intact 
male mice (all three genotypes) treated neonatally 
on days 1–5 with vehicle (control) or 2 μg/day DES. 
Treatment groups: WT control, n = 12; WT DES, 
n = 12; αERKO control, n = 7; αERKO DES, n = 15); 
βERKO control, n = 8; βERKO DES, n = 15). (A) Svs4 
expression in the SV by real-time RT-PCR; expression 
levels were normalized to the Ppia house  keeping 
gene. (B) SVS IV protein expression in SVs; Equal 
protein loading was confirmed with MEMCode total 
protein stain before immuno  blotting. 
*p < 0.05 compared with the corresponding control, by 
ANOVA followed by Tukey’s test. 
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disruption of androgen signaling in this tis­
sue. Because the actions of testosterone and 
its potent metabolite DHT in target cells are 
dependent on the presence of the androgen 
receptor (AR), we assessed Ar in the SVs of 
the different geno  types and treatment groups 
by RT­PCR. Despite exhibiting what appears 
to be androgen resistance, SV tissues of DES­
exposed WT and βERKO males exhibited 
normal levels of Ar when assessed by RT­PCR 
[see Supplemental Material, Figure 1 (http://
dx.doi.org/10.1289/ehp.1103678)]. AR levels 
in the SV tissues of DES­exposed αERKO 
males were also comparable to WT levels. All 
geno  types exhibited a normal pattern of AR 
expression, regardless of neo  natal treatment, 
when assessed by immuno  histochemistry (see 
Supplemental Material, Figure 1).
Given that AR expression patterns were 
normal, we turned our focus to the possibility 
that DES exposure led to a reduction in cir­
culating testosterone levels and hence reduced 
androgen signaling in the SV (Table 1). 
Surprisingly, we found that testosterone levels 
in DES­exposed WT males were somewhat 
elevated, although not statistically signifi­
cant, compared with controls. In βERKO 
males, testosterone levels were normal in both 
treatment groups. Consistent with previ­
ous reports (Lindzey et al. 1998), untreated 
αERKO males exhibited significantly higher 
levels of circulating testosterone relative to 
WT and βERKO males (Table 1). Although 
neo  natal DES exposure appeared to reduce 
testosterone levels in αERKO males, this dif­
ference was not significant compared with 
untreated ERα­null animals, and levels still 
remained 4­ to 5­fold higher than those of 
WT males. Estradiol levels were comparable 
among all genotypes and treatment groups 
[see Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1103678)].
The above data indicate that neo  natal 
DES exposure causes the SV tissues to become 
refractory to androgen stimulation dur­
ing adulthood, despite exhibiting normal Ar 
expression patterns in a milieu of normal cir­
culating testosterone levels. Furthermore, the 
absence of this effect in DES­exposed αERKO 
males strongly suggests that this effect is 
ERα­mediated during development. It is 
conceivable, however, that the remarkably high 
testosterone levels in αERKO mice (Table 1) 
may mask the effects of DES­induced andro­
gen resistance, such as those observed in DES­
exposed WT males. To test this hypothesis, 
control and DES­exposed WT and αERKO 
males were castrated at 10 weeks of age, pro­
vided a Silastic implant of placebo or DHT 
10 days post  surgery, and killed 2 weeks later. 
In this milieu, we assumed that circulating 
androgen levels among the genotypes would 
now be comparable, allowing for more defini­
tive evaluation of the role of ERα and the 
effects of neo  natal DES exposure on the SV. 
As expected, castration led to an acute loss in 
SV weight in both WT and αERKO males 
regardless of neo  natal treatment (Figure 4). 
Two weeks of DHT treatment totally restored 
SV weights in castrated control WT males 
but had no effect in DES­exposed WT 
males. These data definitively demon  strate 
that develop  mental exposure to DES leads to 
androgen resistance in the adult SV. In con­
trast, DHT treatment fully restored castration­
induced losses in SV weights in both control 
and DES­exposed αERKO males. These data 
indicate that αERKO males are largely resis­
tant to the effect of neo  natal DES exposure on 
the SV, providing convincing evidence of the 
importance of ERα in mediating the toxico­
logical effects of DES.
ERα mediates DES-induced molecular 
feminization of SV. The LF gene (Ltf) is an 
estrogen­responsive gene in the uterus and that 
is not normally expressed at measurable levels 
in the SV. However, previous studies have 
shown ectopic LF expression in the SV after 
neo  natal DES exposure in mice (Beckman et al. 
1994; Newbold et al. 1989), indicating DES­
induced “feminization” of the tissue. As we 
expected, in the present study, Ltf expression 
and LF protein were undetectable in SVs 
of control adult males in the thre genotypes 
(Figure 5). In contrast, Ltf expression and 
protein were easily detected in the SVs of 
DES­exposed WT males. We also observed the 
same effect in DES­exposed βERKO males, 
whereas Ltf expression in the SVs of αERKO 
males remained absent regardless of neo­
natal treatment, indicating that DES­induced 
feminization is ERα mediated.
Discussion
Our findings in this study demon  strate 
the importance of ERα in mediating the 
toxicological effects of neo  natal DES exposure 
in the male SV. In WT and βERKO males, 
DES exposure resulted in a reduction in SV 
weight, ectopic expression of Ltf mRNA 
with a concurrent decrease in Svs4 mRNA 
Table 1. Serum levels in intact mice by genotype and treatment.
Control DES
Group n Mean ± SE n Mean ± SE p-Value
Testosterone (ng/mL)
WT 14 160.75 ± 91.22 16 220.77 ± 57.34 0.053
αERKO 11 1011.14 ± 107.24 20 739.23 ± 115.20 0.070
βERKO 6 257.38 ± 183.74 19 229.19 ± 96.56 0.510
Estradiol (pg/mL)
WT 9 25.78 ± 3.58 12 28.46 ± 2.07 0.750
αERKO 6 23.34 ± 6.74 14 30.42 ± 3.08 0.360
βERKO 3 30.42 ± 3.54 15 26.71 ± 1.87 0.380
Statistical significance was determined between control and DES-treated groups within a given genotype by Mann-
Whitney tests. 
Figure 4. SV weight (wt) of male mice (WT and 
αERKO) treated neonatally on days 1–5 with vehicle 
(control) or 2 μg/day DES, castrated at 10 weeks 
of age, and exposed to DHT in Silastic tubing or 
Silastic tubing alone for an additional 2 weeks. 
Treatment groups: without (–) DHT: WT con-
trol, n = 11; WT DES, n = 6; αERKO control, n = 4; 
αERKO DES, n = 10; with (+) DHT: WT control + DHT, 
n = 8; WT DES + DHT, n = 6; αERKO control + DHT, 
n = 7; αERKO DES + DHT, n = 8). 
*p < 0.05 compared with the corresponding control, by 
parametric tests.
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Figure 5. LF expression in SVs of adult intact male 
mice (all three genotypes) treated neonatally on 
days 1–5 with vehicle (control) or 2 μg/day DES. 
Treatment groups: WT control, n = 12; WT DES, 
n = 12; αERKO vehicle, n = 7; αERKO DES, n = 15; 
βERKO control, n = 8; βERKO DES, n = 15. (A) Ltf 
expression in the SV by real-time RT-PCR. All 
expression levels were normalized to the Ppia 
housekeeping gene. (B) LF protein expression in 
SVs; equal protein loading was confirmed with 
MEMCode total protein stain before immuno  blotting 
(data not shown).
*p < 0.05 compared with the corresponding control, by 
ANOVA followed by Tukey’s test. 
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expression, and a permanent resistance to 
androgenic stimulation that was not a result 
of decreased AR levels; these findings suggest 
an ERα­mediated down­stream interference 
with androgen action as a function of early­
life estrogenic exposure. The detrimental and 
permanent effects of develop  mental exposure 
to DES in the mouse male reproductive tract 
have been relatively well described (Marselos 
and Tomatis 1993; Prins 1992; Prins et al. 
2001). In the present study, the hallmark 
histological alterations of DES exposure were 
evident in WT mice. However, the penetrance 
of these effects varied in the βERKO males, 
whereas αERKO males were resistant to the 
detrimental histological alterations. Existing 
evidence that the toxicological effects of 
develop  mental exposure to DES in the female 
reproductive tract and the prostate of males 
are dependent on functional ERα at the 
time of exposure is quite convincing (Couse 
et al. 2001; Couse and Korach 2004; Prins 
et al. 2001). Because many xeno  estrogens, 
including DES, possess properties that can 
potentially disrupt cellu  lar functions apart 
from their ability to act as estrogens, research 
toward a thorough understanding of their 
toxicology has been problematic. Results 
of investigations such as the present study 
using receptor­null mice add to the growing 
evidence that the detrimental effects of 
DES are dependent on functional ERα and 
therefore are attributable to its hormonal 
properties and ability to disrupt endogenous 
estrogen signaling. These data definitively 
show that the developing male reproductive 
tract, although perhaps not dependent on 
estrogens or ER for normal development, 
expresses ER and is quite sensitive to the 
toxicological effects of exogenous estrogens 
when aberrantly exposed. Although the 
risk of DES exposure among humans, 
especially during development, has long 
been diminished (since the mid­1970s), the 
toxicological effects of developmental exposure 
to DES are largely accepted as a harbinger 
of similar potentials among environmental 
and industrial estrogenic compounds, such as 
genistein and bisphenol A, to which humans 
are thought to be exposed.
Perhaps the most prominent effect of 
developmental DES exposure in the reproduc­
tive tract of male mice is a permanent inability 
of the SVs to reach and maintain their normal 
size during adulthood. This hallmark effect 
of DES appears to be due to induction of a 
permanent resistance to androgen stimulation, 
on which growth of the SVs is so dependent, 
because it could not be rescued by a castration/
hormone replacement scheme where animals 
were provided pharmacological levels of andro­
gen for 2 weeks. Further evidence of androgen 
resistance in the SVs after DES exposure is the 
absence of androgen­induced Svs4 expression 
during adulthood. Somewhat similar morpho­
logical and biochemical indicators of androgen 
resistance are observed in the prostate of DES­
exposed mice. However, unlike in the prostate 
where this effect of DES appears to be due at 
least in part to a permanent reduction in AR 
expression (Prins 1992; Prins et al. 2001), we 
demonstrate here that DES­induced androgen 
resistance in the SVs occurs in the presence of 
normal AR expression patterns and circulat­
ing testosterone levels. Our findings are in 
agreement with other reports showing AR lev­
els are not significantly reduced in neo  natally 
exposed SV (Turner et al. 1989). These data 
suggest that the androgen signaling pathway is 
vulnerable to develop  mental exposure to DES 
at multiple points, both at the level of the AR, 
as in the prostate, and at points presumably 
downstream of the AR, as appears to be the 
case in the SV. This latter mechanism may 
involve altered expression of a coregulator that 
is critical to AR function.
The difference in apparent mechanisms 
by which DES exerts its effects in the prostate 
versus SV may be due to the tissues originat­
ing from a different embryonic anlagen, or 
the developmental stage of each at the time 
of exposure. The epithelium of the prostate 
is from the endodermal uro  genital sinus, and 
the epithelium of the SV is from the Wolffian 
duct. The expression of AR is developmentally 
regulated, and expression occurs in different 
parts of the male reproductive tract tempo­
rally, suggesting some differences in develop­
mental programming (Cooke et al. 1991).
In addition to permanent androgen resis­
tance in the SV brought about by neo  natal 
DES exposure, feminized patterns of gene 
expression also occur. Ltf expression is largely 
limited to the epithelial tissues of the female 
reproductive tract under stringent regu  la  tion 
by estradiol/ERα actions and is not normally 
expressed in the male reproductive tract. 
Previous studies, however, have shown that 
mice exposed prenatally to DES express signifi­
cantly high levels of Ltf in the SV (Beckman 
et al. 1994; Newbold et al. 1989; Pentecost 
et al. 1988). Here we demonstrate that this 
DES­induced feminization does not occur in 
the absence of ERα but remains in the absence 
of ERβ. These data demonstrate that ERα is 
fundamental to the molecular feminization 
of the SV. It remains unclear whether the 
observed feminization is also due to the onset 
of androgen resistance, leading to an environ­
ment of unopposed estradiol stimulation, or 
is attributable to a wholly separate disruption 
in normal signaling. Studies have shown that 
uteri of female mice exposed developmen­
tally to DES also have aberrantly high expres­
sion of Ltf in the absence of estrogen (Nelson 
et al. 1994; Newbold et al. 2007). This dys­
regulation has been associated with patterns 
of hypo  methylation of CpG sites near the 
estrogen response element in the Ltf gene in 
uterine tissues of DES­exposed mice (Li et al. 
1997). The ectopic expression of Ltf in the 
SV is plausibly due to a similar mechanism, 
and the absence of this ectopic expression in 
mice lacking ERα suggests that this receptor 
is involved in the epi  genetic changes associ­
ated with neo  natal DES exposure. Further 
studies investigating epi  genetic changes using 
αERKO mice will help elucidate molecular 
events that lead to permanent alterations in 
gene expression.
Conclusion
The data presented here demon  strate that 
ERα plays a role in the develop  mental effects 
resulting from DES toxicity in the SV. ERα is 
involved in the lack of androgen responsive­
ness determined by increases in SV weight 
after DHT treatment and by SVS IV protein 
and Svs4 gene expression, but this does not 
appear to be due to down­regulation of the 
AR itself. Therefore, other factors that con­
trol androgen signaling must be affected. In 
addition, this study definitively shows that 
ERα is necessary for the molecular femini­
zation of the SV after neo  natal exposure to 
DES, because we did not observe aberrant LF 
expression in αERKO mice. 
Irrespective of the underlying mecha­
nisms, the toxicological effects of DES that 
lead to androgen resistance and feminization 
in the SV are dependent on functional ERα. 
Furthermore, this is clearly a toxicological 
effect of aberrant stimulation of ERα signaling 
in the SV during development, as unexposed 
αERKO males invariably exhibited overly 
well­maintained SVs, thus indicating that nor­
mal development and function of the tissue 
are not dependent on functional ERα.
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